Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats

American Journal of Hypertension

Volumn 18, Issue 5, 2005, Pages 699-706

  Naelten, Gaëlle ^a   Liu, Kiao Ling ^a   Chapuis, Bruno ^a   Lo, Ming ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Angiotensin II type 1 receptor antagonist; Angiotensin converting enzyme inhibitor; Hypertension; Renal function

Indexed keywords

LOSARTAN; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG POTENTIATION; DRUG WITHDRAWAL; HYPERTENSION; KIDNEY FUNCTION; MALE; MONOTHERAPY; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TELEMETRY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; HYPERTENSION; KIDNEY; LOSARTAN; MALE; PERINDOPRIL; RATS; RENIN-ANGIOTENSIN SYSTEM;

EID: 18844372515     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.11.033     Document Type: Article

References (31)

1. R.A. Ferrone, M.J. Antonaccio Prevention of the development of spontaneous hypertension in rats by captopril (SQ14, 225) Eur J Pharmacol 60 1979 131 137
2. R.M.K.W. Lee, K.H. Berecek, J. Tsoporis, R. McKenzie, C.R. Triggle Prevention of hypertension and vascular changes by captopril treatment Hypertension 17 1991 141 150
3. C. Richer, M.P. Doussau, J.F. Giudicelli Perindopril, a new converting enzyme inhibitor systemic and regional hemodynamics and sympathoinhibitory effects in spontaneously hypertensive rats J Cardiovasc Pharmacol 8 1986 346 357
4. K.L. Christensen, L.T. Jespersen, M.J. Mulvany Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure J Hypertens 7 1989 83 90
5. J.L. Freslon, J.F. Giudicelli Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats Br J Pharmacol 80 1983 533 543
6. S.B. Harrap, W.M. Van der Merwe, S.A. Griffin, F. MacPherson, A.F. Lever Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term Hypertension 16 1990 603 614
7. K. Skov, J. Fenger-Gron, M.J. Mulvany Effects of an angiotensin- converting enzyme inhibitor, a calcium antagonist, and an endothelin receptor antagonist on renal afferent arteriolar structure Hypertension 28 1996 464 471
8. G. Bergström, I. Johansson, A. Wickman, L. Gan, C. Thorup Brief losartan treatment in young spontaneously hypertensive rats abates long-term blood pressure elevation by effects on renal vascular structure J Hypertens 20 2002 1413 1421
9. L.K. Gillies, M. Lu, H. Wang, R.M.K.W. Lee AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats Hypertension 30 1997 1471 1478
10. C. Smallegange, R.L. Kline, M.A. Adams Transplantation of enalapril-treated kidneys confers persistent lowering of arterial pressure in SHR Hypertension 42 2003 932 936
11. M. Vincent, E.H. Boussaïri, R. Cartier, M. Lo, A. Sassolas, C. Cerutti, C. Barrès, M.P. Gustin, G. Cuisinaud, N.J. Samani, G.M. Lathrop, J. Sassard High blood pressure and metabolic disorders are associated in the Lyon hypertensive rat J Hypertens 11 1993 1179 1185
12. M. Florin, M. Lo, K.L. Liu, J. Sassard Salt sensitivity in genetically hypertensive rats of the Lyon strain Kidney Int 59 2001 1865 1872
13. K.L. Liu, D. Benzoni, J. Sassard Prostaglandin H2-thromboxane A2 and renal functions in the Lyon hypertensive rat Am J Physiol 266 1994 R1530 R1536
14. A. Sarkis, K.L. Liu, M. Lo, D. Benzoni Renal medullary blood flow and salt load in Lyon hypertensive rats Am J Hypertens 15 2002 212 216
15. P. Lantelme, M. Lo, L. Luttenauer, J. Sassard Pivotal role of the renin-angiotensin system in Lyon hypertensive rats Am J Physiol 273 1997 R1793 R1799
16. K.L. Liu, J. Sassard, D. Benzoni In the Lyon hypertensive rat, renal function alterations are angiotensin II dependent Am J Physiol 271 1996 R346 R351
17. D. Bertram, N. Blanc-Brunat, J. Sassard, M. Lo Differential evolution of blood pressure and renal lesions after renin-angiotensin system blockade in Lyon hypertensive rats Am J Physiol 283 2002 R1041 R1045
18. D.J. Campbell, A.M. Duncan, A. Kladis, S.B. Harrap Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats J Cardiovasc Pharmacol 26 1995 426 436
19. P.F. Mento, W.F. Holt, W.R. Murphy, B.M. Wilkes Combined rennin and converting enzyme inhibition in rats Hypertension 13 1989 741 748
20. C.C. Wei, Q.C. Meng, R. Palmer, G.R. Hageman, J. Durand, W.E. Bradley, D.M. Farrell, G.H. Hankes, S. Oparil, L.J. Dell'Italia Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo Circulation 99 1999 2583 2589
21. S. Kim, Y. Zhan, Y. Izumi, H. Iwao Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats Hypertension 35 2000 769 774
22. J. Ménard, D.J. Campbell, M. Azizi, M.F. Gonzales Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats Circulation 96 1997 3072 3078
23. C. Richer-Giudicelli, V. Domergue, M.F. Gonzalez, E. Messadi, M. Azizi, J.F. Giudicelli, J. Ménard Haemodynamic effects of a dual blockade of the rennin-angiotensin system in spontaneously hypertensive rats influence of salt J Hypertens 22 2004 619 627
24. M. Lo, K.L. Liu, J.R. Clemitson, J. Sassard, N.J. Samani Chromosome 1 blood pressure QTL region influences renal function curve and salt sensitivity in SHR Physiol Genomics 8 2001 15 21
25. N. Watanabe, S. Kamei, A. Ohkubo, M. Yamanaka, S. Ohsawa, K. Makino, K. Tokuda Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyser Clin Chem 32 1986 1551 1554
26. R.J. Roman, A.W. Cowley Jr Characterization of a new model for study of pressure-natriuresis in the rat Am J Physiol 248 1985 F190 F198
27. T. Unger, R. Rettig Development of genetic hypertension is there a "critical phase"? Hypertension 16 1990 615 616
28. T. Morgan, C. Griffiths, L. Delbridge Low doses of angiotensin converting enzyme inhibitors and angiotensin type 1 blockers have a synergistic effect but high doses are less than additive Am J Hypertens 15 2002 1003 1005
29. W. Raasch, O. Jöhren, S. Schwartz, A. Gieselberg, P. Dominiak Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR J Hypertens 22 2004 611 618
30. A.C. Guyton Long term arterial pressure control an analysis from animal experiments and computer and graphic models Am J Physiol 259 1990 R865 R877
31. J. Egido Vasoactive hormones and renal sclerosis Kidney Int 49 1996 578 597